Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Clemons, M; Watson, A; Howell, A; Chang, J; Heyworth, C; Lord, B; Testa, N; Dexter, TM; Margison, G
   Macrophage inflammatory protein 1 alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells
   CLINICAL CANCER RESEARCH
   
   M. Clemons et al., "Macrophage inflammatory protein 1 alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells", CLIN CANC R, 6(3), 2000, pp. 966-970
2. Pierce, A; Spooncer, E; Wooley, S; Dive, C; Francis, JM; Miyan, J; Owen-Lynch, PJ; Dexter, TM; Whetton, AD
   Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation
   ONCOGENE
   
   A. Pierce et al., "Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation", ONCOGENE, 19(48), 2000, pp. 5487-5497
3. Dexter, TM
   The role of the Wellcome Trust in support of biomedical research
   JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON
   
   T.M. Dexter, "The role of the Wellcome Trust in support of biomedical research", J ROY COL P, 34(5), 2000, pp. 469-473
4. Francis, JM; Heyworth, CM; Spooncer, E; Pierce, A; Dexter, TM; Whetton, AD
   Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   J.M. Francis et al., "Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells", J BIOL CHEM, 275(50), 2000, pp. 39137-39145
5. McIvor, ZJ; Heyworth, CM; Johnson, BA; Pearson, S; Fiegler, H; Hampson, L; Dexter, TM; Cross, MA
   A transient assay for regulatory gene function in haemopoietic progenitor cells
   BRITISH JOURNAL OF HAEMATOLOGY
   
   Z.J. McIvor et al., "A transient assay for regulatory gene function in haemopoietic progenitor cells", BR J HAEM, 110(3), 2000, pp. 674-681
6. Jelinek, J; Rafferty, JA; Cmejla, R; Hildinger, M; Chinnasamy, D; Lashford, LS; Ostertag, W; Margison, GP; Dexter, TM; Fairbairn, LJ; Baum, C
   A novel dual function retrovirus expressing multidrug resistance 1 and O-6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents
   GENE THERAPY
   
   J. Jelinek et al., "A novel dual function retrovirus expressing multidrug resistance 1 and O-6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents", GENE THER, 6(8), 1999, pp. 1489-1493
7. Durig, J; Testa, NG; Lord, BI; Kasper, C; Chang, J; Telford, N; Dexter, TM; Heyworth, CM
   Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1 alpha
   LEUKEMIA
   
   J. Durig et al., "Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1 alpha", LEUKEMIA, 13(12), 1999, pp. 2012-2022
8. Chinnasamy, N; Rafferty, JA; Lashford, LS; Chinnasamy, D; Margison, GP; Thatcher, N; Dexter, TM; Fairbairn, LJ
   Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy
   LEUKEMIA
   
   N. Chinnasamy et al., "Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy", LEUKEMIA, 13(11), 1999, pp. 1776-1783
9. Johnson, BA; John, VA; Henschler, R; Hampson, IN; Heyworth, CM; Babichuk, CK; Bleackley, RC; Dexter, TM; Cross, MA
   Upstream elements bestow T-cell and haemopoietic progenitor-specific activity on the granzyme B promoter
   GENE
   
   B.A. Johnson et al., "Upstream elements bestow T-cell and haemopoietic progenitor-specific activity on the granzyme B promoter", GENE, 234(1), 1999, pp. 101-107
10. Scheller, M; Foerster, J; Heyworth, CM; Waring, JF; Lohler, J; Gilmore, GL; Shadduck, RK; Dexter, TM; Horak, I
    Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein
    BLOOD
    
    M. Scheller et al., "Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein", BLOOD, 94(11), 1999, pp. 3764-3771
11. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; LASHFORD LS; THATCHER N; MARGISON GP; DEXTER TM; RAFFERTY JA
    CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO
    Gene therapy
    
    I. Hickson et al., "CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO", Gene therapy, 5(6), 1998, pp. 835-841
12. CHINNASAMY N; RAFFERTY JA; HICKSON I; LASHFORD LS; LONGHURST SJ; THATCHER N; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
    CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
    Gene therapy
    
    N. Chinnasamy et al., "CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE", Gene therapy, 5(6), 1998, pp. 842-847
13. MARSHALL E; HOWELL AH; POWLES R; HUNTER MG; EDWARDS M; WOOD LM; CZAPLEWSKI L; PUTTICK R; WARRINGTON S; BOYCE M; TESTA N; DEXTER TM; LORD BI; MILLAR A
    CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010
    European journal of cancer
    
    E. Marshall et al., "CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010", European journal of cancer, 34(7), 1998, pp. 1023-1029
14. PIERCE A; OWENLYNCH PJ; SPOONCER E; DEXTER TM; WHETTON AD
    P210 BCR-ABL EXPRESSION IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELLLINE MODELS THE DEVELOPMENT OF CHRONIC MYELOID-LEUKEMIA
    Oncogene
    
    A. Pierce et al., "P210 BCR-ABL EXPRESSION IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELLLINE MODELS THE DEVELOPMENT OF CHRONIC MYELOID-LEUKEMIA", Oncogene, 17(5), 1998, pp. 667-672
15. WARK G; HEYWORTH CM; SPOONCER E; CZAPLEWSKI L; FRANCIS JM; DEXTER TM; WHETTON AD
    ABL PROTEIN-KINASE ABROGATES THE RESPONSE OF MULTIPOTENT HEMATOPOIETIC-CELLS TO THE GROWTH INHIBITOR MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA
    Oncogene
    
    G. Wark et al., "ABL PROTEIN-KINASE ABROGATES THE RESPONSE OF MULTIPOTENT HEMATOPOIETIC-CELLS TO THE GROWTH INHIBITOR MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA", Oncogene, 16(10), 1998, pp. 1319-1324
16. DURIG J; TESTA NG; LORD BI; KASPER C; CHANG J; TELFORD N; DEXTER TM; HEYWORTH CM
    CHARACTERIZATION OF THE DIFFERENTIAL RESPONSE OF NORMAL AND CML HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA
    Annals of oncology
    
    J. Durig et al., "CHARACTERIZATION OF THE DIFFERENTIAL RESPONSE OF NORMAL AND CML HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA", Annals of oncology, 9, 1998, pp. 384-384
17. PEARSON MA; OFARRELL AM; DEXTER TM; WHETTON AD; OWENLYNCH PJ; HEYWORTH CM
    INVESTIGATION OF THE MOLECULAR MECHANISMS UNDERLYING GROWTH-FACTOR SYNERGY - THE ROLE OF ERK-2 ACTIVATION IN SYNERGY
    Growth factors
    
    M.A. Pearson et al., "INVESTIGATION OF THE MOLECULAR MECHANISMS UNDERLYING GROWTH-FACTOR SYNERGY - THE ROLE OF ERK-2 ACTIVATION IN SYNERGY", Growth factors, 15(4), 1998, pp. 293-306
18. KASPER C; SCHWARZER A; DEWYNTER EA; CHANG J; DEXTER TM; RYDER D; TESTA NG
    RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF) INCREASES THE NUMBERS OF MEGAKARYOCYTE PROGENITOR CELLS TO NORMAL VALUES IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS WITH AML IN FIRST REMISSION
    Leukemia
    
    C. Kasper et al., "RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF) INCREASES THE NUMBERS OF MEGAKARYOCYTE PROGENITOR CELLS TO NORMAL VALUES IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS WITH AML IN FIRST REMISSION", Leukemia, 12(6), 1998, pp. 907-911
19. WEAVER A; CHANG J; WRIGLEY E; DEWYNTER E; WOLL PJ; LIND M; JENKINS B; GILL C; WILKINSON PM; PETTENGELL R; RADFORD JA; COLLINS CD; DEXTER TM; TESTA NG; CROWTHER D
    RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER
    Journal of clinical oncology
    
    A. Weaver et al., "RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER", Journal of clinical oncology, 16(8), 1998, pp. 2601-2612
20. BUREL S; HEYWORTH CM; GEORGE E; DEXTER TM
    THE FACTOR-DEPENDENT CELL-LINE PATERSON MIX AS MODEL SYSTEM FOR ROUTINE ASSESSMENT OF MYELOTOXICITY IN-VITRO
    Experimental hematology
    
    S. Burel et al., "THE FACTOR-DEPENDENT CELL-LINE PATERSON MIX AS MODEL SYSTEM FOR ROUTINE ASSESSMENT OF MYELOTOXICITY IN-VITRO", Experimental hematology, 26(8), 1998, pp. 206-206
21. ROBERTSON J; WYNN R; CROSS M; HATTON C; LASHFORD LS; WILL AM; DEXTER TM; TESTA N
    ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANT
    Bone marrow transplantation
    
    J. Robertson et al., "ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANT", Bone marrow transplantation, 21, 1998, pp. 827-827
22. WYNN RF; CROSS MA; HATTON C; WILL AM; LASHFORD LS; DEXTER TM; TESTA NG
    ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS
    Lancet
    
    R.F. Wynn et al., "ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS", Lancet, 351(9097), 1998, pp. 178-181
23. PIERCE A; WHETTON AD; OWENLYNCH PJ; TAVERNIER J; SPOONCER E; DEXTER TM; HEYWORTH CM
    ECTOPIC INTERLEUKIN-5 RECEPTOR EXPRESSION PROMOTES PROLIFERATION WITHOUT DEVELOPMENT IN A MULTIPOTENT HEMATOPOIETIC-CELL LINE
    Journal of Cell Science
    
    A. Pierce et al., "ECTOPIC INTERLEUKIN-5 RECEPTOR EXPRESSION PROMOTES PROLIFERATION WITHOUT DEVELOPMENT IN A MULTIPOTENT HEMATOPOIETIC-CELL LINE", Journal of Cell Science, 111, 1998, pp. 815-823
24. PIERCE A; HEYWORTH CM; NICHOLLS SE; SPOONCER E; DEXTER TM; LORD JM; OWENLYNCH PJ; WARK G; WHETTON AD
    AN ACTIVATED PROTEIN-KINASE-C-ALPHA GIVES A DIFFERENTIATION SIGNAL FOR HEMATOPOIETIC PROGENITOR CELLS AND MIMICS MACROPHAGE-COLONY-STIMULATING FACTOR-STIMULATED SIGNALING EVENTS
    The Journal of cell biology
    
    A. Pierce et al., "AN ACTIVATED PROTEIN-KINASE-C-ALPHA GIVES A DIFFERENTIATION SIGNAL FOR HEMATOPOIETIC PROGENITOR CELLS AND MIMICS MACROPHAGE-COLONY-STIMULATING FACTOR-STIMULATED SIGNALING EVENTS", The Journal of cell biology, 140(6), 1998, pp. 1511-1518
25. MORRIS EC; KELLY SL; HAMPSON IN; HAMPSON L; DEXTER TM; CARRELL RW; COUGHLIN PB
    NUCLEAR-LOCALIZATION OF HEMATOPOIETIC SERPIN 2A - A POTENTIAL REGULATOR OF APOPTOSIS
    British Journal of Haematology
    
    E.C. Morris et al., "NUCLEAR-LOCALIZATION OF HEMATOPOIETIC SERPIN 2A - A POTENTIAL REGULATOR OF APOPTOSIS", British Journal of Haematology, 101, 1998, pp. 25-25
26. DURIG J; CHANG J; KASPER C; TELFORD N; DEWYNTER EA; TESTA NG; CROSS MA; CHOPRA R; HEYWORTH CM; LORD BI; DEXTER TM
    DIFFERENTIAL RESPONSIVENESS OF CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA)
    British Journal of Haematology
    
    J. Durig et al., "DIFFERENTIAL RESPONSIVENESS OF CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA)", British Journal of Haematology, 101, 1998, pp. 152-152
27. CLEMONS MJ; MARSHALL E; DURIG J; WATANABE K; HOWELL A; MILES D; EARL H; KIERNAN J; GRIFFITHS A; TOWLSON K; DETAKATS P; TESTA NG; DOUGAL M; HUNTER MG; WOOD LM; CZAPLEWSKI LG; MILLAR A; DEXTER TM; LORD BI
    RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
    Blood
    
    M.J. Clemons et al., "RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY", Blood, 92(5), 1998, pp. 1532-1540
28. ENVER T; HEYWORTH CM; DEXTER TM
    DO STEM-CELLS PLAY DICE
    Blood
    
    T. Enver et al., "DO STEM-CELLS PLAY DICE", Blood, 92(2), 1998, pp. 348-351
29. STEWART K; BROWN OA; MORELLI AE; FAIRBAIRN LJ; LASHFORD LS; COOPER A; HATTON CE; DEXTER TM; CASTRO MG; LOWENSTEIN PR
    UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO
    Gene therapy
    
    K. Stewart et al., "UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO", Gene therapy, 4(1), 1997, pp. 63-75
30. WEAVER A; WOLL PJ; LIND M; GILL C; JENKINS B; DEXTER TM; TESTA NG; CROWTHER D
    STEM-CELL FACTOR (R-METHUSCF) IN COMBINATION WITH FILGRASTIM (R-METHUG-CSF) ENHANCES PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION FOLLOWING CHEMOTHERAPY - A RANDOMIZED STUDY
    European journal of cancer
    
    A. Weaver et al., "STEM-CELL FACTOR (R-METHUSCF) IN COMBINATION WITH FILGRASTIM (R-METHUG-CSF) ENHANCES PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION FOLLOWING CHEMOTHERAPY - A RANDOMIZED STUDY", European journal of cancer, 33, 1997, pp. 7-7
31. BUCKINGHAM ME; DEXTER TM
    FROM THE REGULATION OF GROWTH, DIFFERENTIATION, AND DEATH IN-VITRO TOTHE ONSET AND MAINTENANCE OF DIFFERENTIATION IN-VIVO
    Current opinion in genetics & development
    
    M.E. Buckingham e T.M. Dexter, "FROM THE REGULATION OF GROWTH, DIFFERENTIATION, AND DEATH IN-VITRO TOTHE ONSET AND MAINTENANCE OF DIFFERENTIATION IN-VIVO", Current opinion in genetics & development, 7(5), 1997, pp. 577-581
32. RAFFERTY JA; CHINNASAMY N; HICKSON I; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
    GENE-THERAPY FOR CHEMOPROTECTION OF BONE-MARROW FROM THE TOXIC AND CARCINOGENIC EFFECTS OF THE O-6-ALKYLATING AGENTS
    Cancer gene therapy
    
    J.A. Rafferty et al., "GENE-THERAPY FOR CHEMOPROTECTION OF BONE-MARROW FROM THE TOXIC AND CARCINOGENIC EFFECTS OF THE O-6-ALKYLATING AGENTS", Cancer gene therapy, 4(6), 1997, pp. 89-89
33. CHINNASAMY N; HICKSON I; DEXTER TM; MARGISON GP; FAIRBAIRN LJ; RAFFERTY JA
    GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
    Cancer gene therapy
    
    N. Chinnasamy et al., "GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE", Cancer gene therapy, 4(5), 1997, pp. 303-303
34. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; DEXTER TM; MARGISON GP; RAFFERTY JA
    TOWARDS GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
    Cancer gene therapy
    
    I. Hickson et al., "TOWARDS GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE", Cancer gene therapy, 4(1), 1997, pp. 70-70
35. DURIG J; DEWYNTER EA; KASPER C; CHANG J; DEXTER TM; CROSS M; HEYWORTH CM; TESTA NG
    DIFFERENTIAL MIP-1-ALPHA-RESPONSIVENESS IN CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS
    Experimental hematology
    
    J. Durig et al., "DIFFERENTIAL MIP-1-ALPHA-RESPONSIVENESS IN CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS", Experimental hematology, 25(8), 1997, pp. 120-120
36. COUTINHO LH; CHANG J; BRERETON ML; MORGENSTERN GR; SCARFFE JH; HARRISON CJ; YIN JAL; DARBYSHIRE PJ; BURDACH S; DEXTER TM; TESTA NG
    AUTOGRAFTING IN PHILADELPHIA (PH)-LEUKEMIA USING CULTURED MARROW - ANUPDATE OF A PILOT-STUDY( CHRONIC MYELOID)
    Bone marrow transplantation
    
    L.H. Coutinho et al., "AUTOGRAFTING IN PHILADELPHIA (PH)-LEUKEMIA USING CULTURED MARROW - ANUPDATE OF A PILOT-STUDY( CHRONIC MYELOID)", Bone marrow transplantation, 19(10), 1997, pp. 969-976
37. REIPERT BM; ALLAN D; REIPERT S; DEXTER TM
    APOPTOSIS IN HEMATOPOIETIC PROGENITOR CELLS EXPOSED TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS
    Life sciences
    
    B.M. Reipert et al., "APOPTOSIS IN HEMATOPOIETIC PROGENITOR CELLS EXPOSED TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS", Life sciences, 61(16), 1997, pp. 1571-1582
38. SCHOFIELD KP; RUSHTON G; HUMPHRIES MJ; DEXTER TM; GALLAGHER JT
    INFLUENCE OF INTERLEUKIN-3 AND OTHER GROWTH-FACTORS ON ALPHA(4)BETA(1) INTEGRIN-MEDIATED ADHESION AND MIGRATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS
    Blood
    
    K.P. Schofield et al., "INFLUENCE OF INTERLEUKIN-3 AND OTHER GROWTH-FACTORS ON ALPHA(4)BETA(1) INTEGRIN-MEDIATED ADHESION AND MIGRATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS", Blood, 90(5), 1997, pp. 1858-1866
39. OGORMAN P; COLLINS JK; OSULLIVAN GC; ODONOGHUE M; SHANAHAN F; DEXTER TM
    A TUMOR-DERIVED MOLECULE INDUCES APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA AND MEDIATES SELECTIVE HEMATOPOIETIC PROGENITOR SUPPRESSION
    Blood
    
    P. Ogorman et al., "A TUMOR-DERIVED MOLECULE INDUCES APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA AND MEDIATES SELECTIVE HEMATOPOIETIC PROGENITOR SUPPRESSION", Blood, 90(10), 1997, pp. 359-359
40. CHINNASAMY N; RAFFERTY JA; HICKSON I; ASHBY J; TINWELL H; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
    O-6-BENZYLGUANINE POTENTIATES THE IN-VIVO TOXICITY AND CLASTOGENICITYOF TEMOZOLOMIDE AND BCNU IN MOUSE BONE-MARROW
    Blood
    
    N. Chinnasamy et al., "O-6-BENZYLGUANINE POTENTIATES THE IN-VIVO TOXICITY AND CLASTOGENICITYOF TEMOZOLOMIDE AND BCNU IN MOUSE BONE-MARROW", Blood, 89(5), 1997, pp. 1566-1573
41. HAMPSON IN; HAMPSON L; PINKOSKI M; CROSS M; HEYWORTH CM; BLEACKLEY RC; ATKINSON E; DEXTER TM
    IDENTIFICATION OF A SERPIN SPECIFICALLY EXPRESSED IN MULTIPOTENT AND BIPOTENT HEMATOPOIETIC PROGENITOR CELLS AND IN ACTIVATED T-CELLS
    Blood
    
    I.N. Hampson et al., "IDENTIFICATION OF A SERPIN SPECIFICALLY EXPRESSED IN MULTIPOTENT AND BIPOTENT HEMATOPOIETIC PROGENITOR CELLS AND IN ACTIVATED T-CELLS", Blood, 89(1), 1997, pp. 108-118
42. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; DEXTER TM; MARGISON GP; RAFFERTY JA
    PROTECTION OF MAMMALIAN-CELLS AGAINST CHLOROETHYLATING AGENT TOXICITYBY AN O-6-BENZYLGUANINE-RESISTANT MUTANT OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
    Gene therapy
    
    I. Hickson et al., "PROTECTION OF MAMMALIAN-CELLS AGAINST CHLOROETHYLATING AGENT TOXICITYBY AN O-6-BENZYLGUANINE-RESISTANT MUTANT OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE", Gene therapy, 3(10), 1996, pp. 868-877
43. BRETTI S; GILLEECE MH; KAMTHAN A; FITZSIMMONS L; HICKS F; ROWLANDS M; BISHOP P; PICARDO AM; DEXTER TM; SCARFFE JH
    AN OPEN PHASE-I STUDY TO ASSESS THE BIOLOGICAL EFFECTS OF A CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 FOLLOWED BY GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR
    European journal of cancer
    
    S. Bretti et al., "AN OPEN PHASE-I STUDY TO ASSESS THE BIOLOGICAL EFFECTS OF A CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 FOLLOWED BY GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR", European journal of cancer, 32A(7), 1996, pp. 1171-1178
44. BAUMANN I; SWINDELL R; VANHOEFF MEHM; DEXTER TM; DEWYNTER E; LANGE C; LUFT T; HOWELL A; TESTA NG
    MOBILIZATION KINETICS OF PRIMITIVE HEMATOPOIETIC-CELLS FOLLOWING G-CSF WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
    Annals of oncology
    
    I. Baumann et al., "MOBILIZATION KINETICS OF PRIMITIVE HEMATOPOIETIC-CELLS FOLLOWING G-CSF WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED BREAST-CANCER", Annals of oncology, 7(10), 1996, pp. 1051-1057
45. REIPERT BM; ALLAN D; DEXTER TM
    EXPOSURE TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS HAS NO EFFECT ON GROWTH-RATE OR CLONOGENIC POTENTIAL OF MULTIPOTENTIAL HEMATOPOIETIC PROGENITOR CELLS
    Growth factors
    
    B.M. Reipert et al., "EXPOSURE TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS HAS NO EFFECT ON GROWTH-RATE OR CLONOGENIC POTENTIAL OF MULTIPOTENTIAL HEMATOPOIETIC PROGENITOR CELLS", Growth factors, 13(3-4), 1996, pp. 205-217
46. HAMPSON IN; HAMPSON L; DEXTER TM
    DIRECTIONAL RANDOM OLIGONUCLEOTIDE PRIMED (DROP) GLOBAL AMPLIFICATIONOF CDNA - ITS APPLICATION TO SUBTRACTIVE CDNA CLONING
    Nucleic acids research
    
    I.N. Hampson et al., "DIRECTIONAL RANDOM OLIGONUCLEOTIDE PRIMED (DROP) GLOBAL AMPLIFICATIONOF CDNA - ITS APPLICATION TO SUBTRACTIVE CDNA CLONING", Nucleic acids research, 24(23), 1996, pp. 4832-4835
47. WEAVER A; RYDER D; DEXTER TM; CROWTHER D; TESTA NG
    INCREASING NUMBERS OF LONG-TERM CULTURE - INITIATING CELLS (LTC-IC) ARE MOBILIZED INTO THE PERIPHERAL-BLOOD WITH INCREASING DOSES OF STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) AND CHEMOTHERAPY
    Experimental hematology
    
    A. Weaver et al., "INCREASING NUMBERS OF LONG-TERM CULTURE - INITIATING CELLS (LTC-IC) ARE MOBILIZED INTO THE PERIPHERAL-BLOOD WITH INCREASING DOSES OF STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) AND CHEMOTHERAPY", Experimental hematology, 24(9), 1996, pp. 97-97
48. HEYWORTH CM; DEXTER TM; CROSS MA; ALLEN TD; TESTA NG
    MEGAKARYOCYTIC DEVELOPMENT OF A MULTIPOTENT STEM-CELL LINE, FDCP-MIX
    Experimental hematology
    
    C.M. Heyworth et al., "MEGAKARYOCYTIC DEVELOPMENT OF A MULTIPOTENT STEM-CELL LINE, FDCP-MIX", Experimental hematology, 24(9), 1996, pp. 257-257
49. WARK G; PIERCE A; LORD JM; HEYWORTH CM; SPOONCER E; DEXTER TM; WHETTON AD
    RETROVIRAL INFECTION OF GRANULOCYTE-MACROPHAGE PROGENITOR CELLS WITH CONSTITUTIVELY ACTIVE PROTEIN-KINASE C-ALPHA PROMOTES MACROPHAGE DEVELOPMENT
    Experimental hematology
    
    G. Wark et al., "RETROVIRAL INFECTION OF GRANULOCYTE-MACROPHAGE PROGENITOR CELLS WITH CONSTITUTIVELY ACTIVE PROTEIN-KINASE C-ALPHA PROMOTES MACROPHAGE DEVELOPMENT", Experimental hematology, 24(9), 1996, pp. 451-451
50. KASPER C; SCHWARZER A; DEWYNTER FA; CHANG J; DEXTER TM; TESTA NG
    STIMULATORY EFFECTS OF RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS OF ACUTEMYELOID-LEUKEMIA
    Experimental hematology
    
    C. Kasper et al., "STIMULATORY EFFECTS OF RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS OF ACUTEMYELOID-LEUKEMIA", Experimental hematology, 24(9), 1996, pp. 554-554
51. RAFFERTY JA; HICKSON I; CHINNASAMY N; LASHFORD LS; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
    CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES
    Cancer metastasis reviews
    
    J.A. Rafferty et al., "CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES", Cancer metastasis reviews, 15(3), 1996, pp. 365-383
52. FAIRBAIRN LJ; LASHFORD LS; SPOONCER E; MCDERMOTT RH; LEBENS G; ARRAND JE; ARRAND JR; BELLANTUONO I; HOLT R; HATTON CE; COOPER A; BESLEY GTN; WRAITH JE; ANSON DS; HOPWOOD JJ; DEXTER TM
    LONG-TERM IN-VITRO CORRECTION OF ALPHA-L-IDURONIDASE DEFICIENCY (HURLER-SYNDROME) IN HUMAN BONE-MARROW
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    L.J. Fairbairn et al., "LONG-TERM IN-VITRO CORRECTION OF ALPHA-L-IDURONIDASE DEFICIENCY (HURLER-SYNDROME) IN HUMAN BONE-MARROW", Proceedings of the National Academy of Sciences of the United Statesof America, 93(5), 1996, pp. 2025-2030
53. MARGISON GP; RAFFERTY JA; ELDER RH; KELLY J; WATSON AJ; WILLINGTON MA; LEE SM; HICKSON I; FAIRBAIRN LJ; DEXTER TM; JELINEK J; STOCKING C; BAUM C; OSTERTAG W; EGHYAZI S; HANSSON J; RINGBORG U; DONNELLY D; MCMURRY TBH; MCCORMICK J; MCELHINNEY RS
    MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE
    Medicamentos de actualidad
    
    G.P. Margison et al., "MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE", Medicamentos de actualidad, 32, 1996, pp. 51-59
54. GILLEECE MH; HEYWORTH CM; TESTA NG; DEXTER TM
    EFFECTS OF INTERLEUKINS ON THE PROLIFERATION AND SURVIVAL OF CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    Journal of Clinical Pathology
    
    M.H. Gilleece et al., "EFFECTS OF INTERLEUKINS ON THE PROLIFERATION AND SURVIVAL OF CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS", Journal of Clinical Pathology, 49(5), 1996, pp. 437-438
55. COUTINHO LH; BRERETON ML; SANTOS AMW; RYDER WDJ; CHANG J; HARRISON CJ; YIN JAL; DEXTER TM; TESTA NG
    EVALUATION OF CYTOGENETIC CONVERSION TO PH(-) HEMATOPOIESIS IN LONG-TERM BONE-MARROW CULTURE FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA ON CONVENTIONAL HYDROXYUREA THERAPY, ON PULSE HIGH-DOSE HYDROXYUREA AND ON INTERFERON-ALPHA
    British Journal of Haematology
    
    L.H. Coutinho et al., "EVALUATION OF CYTOGENETIC CONVERSION TO PH(-) HEMATOPOIESIS IN LONG-TERM BONE-MARROW CULTURE FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA ON CONVENTIONAL HYDROXYUREA THERAPY, ON PULSE HIGH-DOSE HYDROXYUREA AND ON INTERFERON-ALPHA", British Journal of Haematology, 93(4), 1996, pp. 869-877
56. OGORMAN P; COTTER P; COLLINS JK; OSULLIVAN G; ODONOGHUE M; SHANAHAN F; DEWYNTER E; DEXTER TM
    A TUMOR-DERIVED MOLECULE MEDIATES HEMATOPOIETIC STEM-CELL SUPPRESSION
    British Journal of Haematology
    
    P. Ogorman et al., "A TUMOR-DERIVED MOLECULE MEDIATES HEMATOPOIETIC STEM-CELL SUPPRESSION", British Journal of Haematology, 93, 1996, pp. 192-192
57. WEAVER A; WRIGLEY E; WATSON A; CHANG J; COLLINS CD; JENKINS B; GILL C; PETTENGELL R; DEXTER TM; TESTA NG; CROWTHER D
    A STUDY OF OVARIAN-CANCER PATIENTS TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM AND CYCLOPHOSPHAMIDE
    British Journal of Cancer
    
    A. Weaver et al., "A STUDY OF OVARIAN-CANCER PATIENTS TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM AND CYCLOPHOSPHAMIDE", British Journal of Cancer, 74(11), 1996, pp. 1821-1827
58. WEAVER A; RYDER D; CROWTHER D; DEXTER TM; TESTA NG
    INCREASED NUMBERS OF LONG-TERM CULTURE-INITIATING CELLS IN THE APHERESIS PRODUCT OF PATIENTS RANDOMIZED TO RECEIVE INCREASING DOSES OF STEM-CELL FACTOR ADMINISTERED IN COMBINATION WITH CHEMOTHERAPY AND A STANDARD-DOSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR
    Blood
    
    A. Weaver et al., "INCREASED NUMBERS OF LONG-TERM CULTURE-INITIATING CELLS IN THE APHERESIS PRODUCT OF PATIENTS RANDOMIZED TO RECEIVE INCREASING DOSES OF STEM-CELL FACTOR ADMINISTERED IN COMBINATION WITH CHEMOTHERAPY AND A STANDARD-DOSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR", Blood, 88(9), 1996, pp. 3323-3328
59. JELINEK J; FAIRBAIRN LJ; DEXTER TM; RAFFERTY JA; STOCKING C; OSTERTAG W; MARGISON GP
    LONG-TERM PROTECTION OF HEMATOPOIESIS AGAINST THE CYTOTOXIC EFFECTS OF MULTIPLE DOSES OF NITROSOUREA BY RETROVIRUS-MEDIATED EXPRESSION OF HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE
    Blood
    
    J. Jelinek et al., "LONG-TERM PROTECTION OF HEMATOPOIESIS AGAINST THE CYTOTOXIC EFFECTS OF MULTIPLE DOSES OF NITROSOUREA BY RETROVIRUS-MEDIATED EXPRESSION OF HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE", Blood, 87(5), 1996, pp. 1957-1961
60. HEYWORTH CM; PEARSON MA; DEXTER TM; WARK G; OWENLYNCH PJ; WHETTON AD
    MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MEDIATED GROWTH-INHIBITION INA HEMATOPOIETIC STEM-CELL LINE IS ASSOCIATED WITH INOSITOL 1,4,5-TRISPHOSPHATE GENERATION
    Growth factors
    
    C.M. Heyworth et al., "MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MEDIATED GROWTH-INHIBITION INA HEMATOPOIETIC STEM-CELL LINE IS ASSOCIATED WITH INOSITOL 1,4,5-TRISPHOSPHATE GENERATION", Growth factors, 12(3), 1995, pp. 165-172
61. JUST U; KAN O; FENNELLY J; DEXTER TM; SPOONCER E
    THE HOX-2.4 GENE IS NOT INVOLVED IN THE GENERATION OF IL-3 DEPENDENT MULTIPOTENT FDCP-MIX CELL-LINES
    Growth factors
    
    U. Just et al., "THE HOX-2.4 GENE IS NOT INVOLVED IN THE GENERATION OF IL-3 DEPENDENT MULTIPOTENT FDCP-MIX CELL-LINES", Growth factors, 12(3), 1995, pp. 173-177
62. PETTENGELL R; WOLL PJ; THATCHER N; DEXTER TM; TESTA NG
    MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD
    Journal of clinical oncology
    
    R. Pettengell et al., "MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD", Journal of clinical oncology, 13(1), 1995, pp. 148-156
63. PEARSON M; OWEN PJ; WHETTON AD; DEXTER TM; HEYWORTH CM
    INVESTIGATION OF THE MOLECULAR MECHANISMS BY WHICH SCF SYNERGISTICALLY PROMOTES THE EFFECTS OF CYTOKINES ON FDCP-MIX A4 CELLS
    Experimental hematology
    
    M. Pearson et al., "INVESTIGATION OF THE MOLECULAR MECHANISMS BY WHICH SCF SYNERGISTICALLY PROMOTES THE EFFECTS OF CYTOKINES ON FDCP-MIX A4 CELLS", Experimental hematology, 23(8), 1995, pp. 827-827
64. WARK G; WHETTON AD; SPOONCER E; HEYWORTH CM; DEXTER TM
    MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA PROTECTS A HEMATOPOIETIC MULTIPOTENT STEM-CELL LINE FROM THE CYTOTOXIC EFFECTS OF CYCLE-SPECIFIC AGENTS - MODULATION BY ACTIVATION OF V-ABL PROTEIN-TYROSINE KINASE
    Experimental hematology
    
    G. Wark et al., "MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA PROTECTS A HEMATOPOIETIC MULTIPOTENT STEM-CELL LINE FROM THE CYTOTOXIC EFFECTS OF CYCLE-SPECIFIC AGENTS - MODULATION BY ACTIVATION OF V-ABL PROTEIN-TYROSINE KINASE", Experimental hematology, 23(8), 1995, pp. 883-883
65. LANGE C; HUMPHRIES MJ; TESTA NG; DEXTER TM
    DECREASED LEUKEMIC-CELL ADHESION DOES NOT INVOLVE FIBRONECTIN DERIVEDCS-I REGION
    Experimental hematology
    
    C. Lange et al., "DECREASED LEUKEMIC-CELL ADHESION DOES NOT INVOLVE FIBRONECTIN DERIVEDCS-I REGION", Experimental hematology, 23(8), 1995, pp. 932-932
66. LORD BI; DEXTER TM
    WHICH ARE THE HEMATOPOIETIC STEM-CELLS
    Experimental hematology
    
    B.I. Lord e T.M. Dexter, "WHICH ARE THE HEMATOPOIETIC STEM-CELLS", Experimental hematology, 23(12), 1995, pp. 1237-1241
67. NICHOLLS SE; HEYWORTH CM; DEXTER TM; LORD JM; JOHNSON GD; WHETTON AD
    IL-4 PROMOTES MACROPHAGE DEVELOPMENT BY RAPIDLY STIMULATING LINEAGE RESTRICTION OF BIPOTENT GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS
    The Journal of immunology
    
    S.E. Nicholls et al., "IL-4 PROMOTES MACROPHAGE DEVELOPMENT BY RAPIDLY STIMULATING LINEAGE RESTRICTION OF BIPOTENT GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS", The Journal of immunology, 155(2), 1995, pp. 845-853
68. HEYWORTH CM; ALAULDIN M; CROSS MA; FAIRBAIRN LJ; DEXTER TM; WHETTON AD
    ERYTHROID DEVELOPMENT OF THE FDCP-MIX A4 MULTIPOTENT CELL-LINE IS GOVERNED BY THE RELATIVE CONCENTRATIONS OF ERYTHROPOIETIN AND INTERLEUKIN-3
    British Journal of Haematology
    
    C.M. Heyworth et al., "ERYTHROID DEVELOPMENT OF THE FDCP-MIX A4 MULTIPOTENT CELL-LINE IS GOVERNED BY THE RELATIVE CONCENTRATIONS OF ERYTHROPOIETIN AND INTERLEUKIN-3", British Journal of Haematology, 91(1), 1995, pp. 15-22
69. RAGHAVACHAR A; JANSSEN JWG; SCHREZENMEIER H; WAGNER B; BARTRAM CR; SCHULZ AS; HEIN C; COWLING G; MUBARIK A; TESTA NG; DEXTER TM; HOWS JM; MARSH JCW
    CLONAL HEMATOPOIESIS AS DEFINED BY POLYMORPHIC X-LINKED LOCI OCCURS INFREQUENTLY IN APLASTIC-ANEMIA
    Blood
    
    A. Raghavachar et al., "CLONAL HEMATOPOIESIS AS DEFINED BY POLYMORPHIC X-LINKED LOCI OCCURS INFREQUENTLY IN APLASTIC-ANEMIA", Blood, 86(8), 1995, pp. 2938-2947
70. HUNTER MG; BAWDEN L; BROTHERTON D; CRAIG S; CRIBBES S; CZAPLEWSKI LG; DEXTER TM; DRUMMOND AH; GEARING AH; HEYWORTH CM; LORD BI; MCCOURT M; VARLEY PG; WOOD LM; EDWARDS RM; LEWIS PJ
    BB-10010 - AN ACTIVE VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA WITH IMPROVED PHARMACEUTICAL PROPERTIES
    Blood
    
    M.G. Hunter et al., "BB-10010 - AN ACTIVE VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA WITH IMPROVED PHARMACEUTICAL PROPERTIES", Blood, 86(12), 1995, pp. 4400-4408
71. HU M; HEYWORTH C; DEXTER TM; ENVER T
    SIMULTANEOUS ACTIVATION OF ERYTHROID AND MYELOID TRANSCRIPTIONAL PROGRAMS IN INDIVIDUAL MULTIPOTENTIAL HEMATOPOIETIC-CELLS PRIOR TO UNILINEAGE COMMITMENT AND DIFFERENTIATION
    Blood
    
    M. Hu et al., "SIMULTANEOUS ACTIVATION OF ERYTHROID AND MYELOID TRANSCRIPTIONAL PROGRAMS IN INDIVIDUAL MULTIPOTENTIAL HEMATOPOIETIC-CELLS PRIOR TO UNILINEAGE COMMITMENT AND DIFFERENTIATION", Blood, 86(10), 1995, pp. 1204-1204
72. LASKAY G; VARHELYI T; DALE RE; DEXTER TM
    ROLE OF INTERLEUKIN-3 IN THE REGULATION OF INTERCELLULAR K-CELLS( HOMEOSTASIS IN CULTURED MURINE HEMATOPOIETIC)
    Biochemical and biophysical research communications
    
    G. Laskay et al., "ROLE OF INTERLEUKIN-3 IN THE REGULATION OF INTERCELLULAR K-CELLS( HOMEOSTASIS IN CULTURED MURINE HEMATOPOIETIC)", Biochemical and biophysical research communications, 214(2), 1995, pp. 348-353
73. COWLING GJ; DEXTER TM
    APOPTOSIS IN THE HEMATOPOIETIC SYSTEM
    Philosophical transactions-Royal Society of London. Biological sciences
    
    G.J. Cowling e T.M. Dexter, "APOPTOSIS IN THE HEMATOPOIETIC SYSTEM", Philosophical transactions-Royal Society of London. Biological sciences, 345(1313), 1994, pp. 257-263
74. DEXTER TM
    GRANULOCYTE-COLONY-STIMULATING FACTOR - FROM LABORATORY BENCH TO CLINICAL USE
    European journal of cancer
    
    T.M. Dexter, "GRANULOCYTE-COLONY-STIMULATING FACTOR - FROM LABORATORY BENCH TO CLINICAL USE", European journal of cancer, 30A, 1994, pp. 15-19
75. CROSS MA; HEYWORTH CM; MURRELL AM; BOCKAMP EO; DEXTER TM; GREEN AR
    EXPRESSION OF LINEAGE RESTRICTED TRANSCRIPTION FACTORS PRECEDES LINEAGE-SPECIFIC DIFFERENTIATION IN A MULTIPOTENT HEMATOPOIETIC PROGENITOR-CELL LINE
    Oncogene
    
    M.A. Cross et al., "EXPRESSION OF LINEAGE RESTRICTED TRANSCRIPTION FACTORS PRECEDES LINEAGE-SPECIFIC DIFFERENTIATION IN A MULTIPOTENT HEMATOPOIETIC PROGENITOR-CELL LINE", Oncogene, 9(10), 1994, pp. 3013-3016
76. DEXTER TM; HEYWORTH CM
    GROWTH-FACTORS AND THE MOLECULAR CONTROL OF HEMATOPOIESIS
    European journal of clinical microbiology & infectious diseases
    
    T.M. Dexter e C.M. Heyworth, "GROWTH-FACTORS AND THE MOLECULAR CONTROL OF HEMATOPOIESIS", European journal of clinical microbiology & infectious diseases, 13, 1994, pp. 190000003-190000008
77. VANHOEF MEHM; BAUMANN I; LANGE C; LUFT T; DEWYNTER EA; RANSON M; MORGENSTERN GR; YVERS A; DEXTER TM; TESTA NG; HOWELL A
    DOSE-ESCALATING INDUCTION CHEMOTHERAPY SUPPORTED BY LENOGRASTIM PRECEDING HIGH-DOSE CONSOLIDATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER -SELECTION OF THE MOST ACCEPTABLE REGIMEN TO INDUCE MAXIMAL TUMOR RESPONSE AND INVESTIGATION OF THE OPTIMAL TIME TO COLLECT PERIPHERAL-BLOODPROGENITOR CELLS FOR HEMATOLOGICAL RESCUE AFTER HIGH-DOSE CONSOLIDATION CHEMOTHERAPY
    Annals of oncology
    
    M.E.H.M. Vanhoef et al., "DOSE-ESCALATING INDUCTION CHEMOTHERAPY SUPPORTED BY LENOGRASTIM PRECEDING HIGH-DOSE CONSOLIDATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER -SELECTION OF THE MOST ACCEPTABLE REGIMEN TO INDUCE MAXIMAL TUMOR RESPONSE AND INVESTIGATION OF THE OPTIMAL TIME TO COLLECT PERIPHERAL-BLOODPROGENITOR CELLS FOR HEMATOLOGICAL RESCUE AFTER HIGH-DOSE CONSOLIDATION CHEMOTHERAPY", Annals of oncology, 5(3), 1994, pp. 217-224
78. STRAKA C; PETTENGELL R; PIELMEIER A; CROSS M; EMMERICH B; CROWTHER D; TESTA NG; DEXTER TM
    A RELIABLE APPROACH FOR SEQUENCING CLONE-SPECIFIC CDRIII REGIONS IN B-CELL LYMPHOMA
    Annals of oncology
    
    C. Straka et al., "A RELIABLE APPROACH FOR SEQUENCING CLONE-SPECIFIC CDRIII REGIONS IN B-CELL LYMPHOMA", Annals of oncology, 5, 1994, pp. 190000079-190000084
79. FAIRBAIRN LJ; COWLING GJ; DEXTER TM; RAFFERTY JA; MARGISON GP; REIPERT B
    BCL-2 DELAY OF ALKYLATING AGENT-INDUCED APOPTOTIC DEATH IN A MURINE HEMATOPOIETIC STEM-CELL LINE
    Molecular carcinogenesis
    
    L.J. Fairbairn et al., "BCL-2 DELAY OF ALKYLATING AGENT-INDUCED APOPTOTIC DEATH IN A MURINE HEMATOPOIETIC STEM-CELL LINE", Molecular carcinogenesis, 11(1), 1994, pp. 49-55
80. SPOONCER E; FAIRBAIRN L; COWLING GJ; DEXTER TM; WHETTON AD; OWENLYNCH PJ
    BIOLOGICAL CONSEQUENCES OF P160(V-ABL) PROTEIN-TYROSINE KINASE-ACTIVITY IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELL LINE
    Leukemia
    
    E. Spooncer et al., "BIOLOGICAL CONSEQUENCES OF P160(V-ABL) PROTEIN-TYROSINE KINASE-ACTIVITY IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELL LINE", Leukemia, 8(4), 1994, pp. 620-630
81. JUST U; SPOONCER E; LOHLER J; STOCKING C; OSTERTAG W; DEXTER TM
    MUTANTS OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE BLOCKED IN GM-CSF-INDUCED DIFFERENTIATION ARE LEUKEMOGENIC IN-VIVO
    Experimental hematology
    
    U. Just et al., "MUTANTS OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE BLOCKED IN GM-CSF-INDUCED DIFFERENTIATION ARE LEUKEMOGENIC IN-VIVO", Experimental hematology, 22(9), 1994, pp. 933-940
82. BAUMANN I; VANHOEF MEHM; SWINDELL R; LANGE C; DEWYNTER E; HOWELL A; DEXTER TM; TESTA NG
    THE PEAK NUMBERS OF COLONY-FORMING CELLS AND OF CD34-BLOOD AFTER G-CSF (LENOGRASTIM) WITH OR WITHOUT CHEMOTHERAPY MAY NOT BE CORRELATED WITH THE CAPACITY OF HARVESTED BLOOD-CELLS TO REPOPULATE BONE-MARROW( CELLS RELEASED INTO PERIPHERAL)
    Experimental hematology
    
    I. Baumann et al., "THE PEAK NUMBERS OF COLONY-FORMING CELLS AND OF CD34-BLOOD AFTER G-CSF (LENOGRASTIM) WITH OR WITHOUT CHEMOTHERAPY MAY NOT BE CORRELATED WITH THE CAPACITY OF HARVESTED BLOOD-CELLS TO REPOPULATE BONE-MARROW( CELLS RELEASED INTO PERIPHERAL)", Experimental hematology, 22(8), 1994, pp. 765-765
83. WHETTON AD; HEYWORTH CM; LORD JL; DEXTER TM; NICHOLLS S; OWENLYNCH PJ
    CYTOKINE-STIMULATED PROTEIN-KINASE-C-ALPHA TRANSLOCATION TO THE NUCLEUS IS ASSOCIATED WITH COMMITMENT OF BIPOTENTIAL GRANULOCYTE-MACROPHAGECOLONY-FORMING CELLS TO MACROPHAGE DEVELOPMENT
    Experimental hematology
    
    A.D. Whetton et al., "CYTOKINE-STIMULATED PROTEIN-KINASE-C-ALPHA TRANSLOCATION TO THE NUCLEUS IS ASSOCIATED WITH COMMITMENT OF BIPOTENTIAL GRANULOCYTE-MACROPHAGECOLONY-FORMING CELLS TO MACROPHAGE DEVELOPMENT", Experimental hematology, 22(8), 1994, pp. 832-832
84. HEYWORTH CM; DEXTER TM; NICHOLLS SE; WHETTON AD
    COMBINATIONS OF COLONY-STIMULATING FACTORS PROMOTE ENHANCED PROLIFERATIVE POTENTIAL IN ENRICHED GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS
    Experimental hematology
    
    C.M. Heyworth et al., "COMBINATIONS OF COLONY-STIMULATING FACTORS PROMOTE ENHANCED PROLIFERATIVE POTENTIAL IN ENRICHED GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS", Experimental hematology, 22(11), 1994, pp. 1089-1094
85. PETTENGELL R; WOLL PJ; OCONNOR DA; DEXTER TM; TESTA NG
    VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME
    Bone marrow transplantation
    
    R. Pettengell et al., "VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME", Bone marrow transplantation, 14(5), 1994, pp. 703-709
86. WHETTON AD; HEYWORTH CM; NICHOLLS SE; EVANS CA; LORD JM; DEXTER TM; OWENLYNCH PJ
    CYTOKINE-MEDIATED PROTEIN-KINASE-C ACTIVATION IS A SIGNAL FOR LINEAGEDETERMINATION IN BIPOTENTIAL GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS
    The Journal of cell biology
    
    A.D. Whetton et al., "CYTOKINE-MEDIATED PROTEIN-KINASE-C ACTIVATION IS A SIGNAL FOR LINEAGEDETERMINATION IN BIPOTENTIAL GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS", The Journal of cell biology, 125(3), 1994, pp. 651-659
87. DEXTER TM; CHANG J
    NEW STRATEGIES FOR THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA
    Blood
    
    T.M. Dexter e J. Chang, "NEW STRATEGIES FOR THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA", Blood, 84(3), 1994, pp. 673-675
88. PETTENGELL R; LUFT T; HENSCHLER R; HOWS JM; DEXTER TM; RYDER D; TESTA NG
    DIRECT COMPARISON BY LIMITING DILUTION ANALYSIS OF LONG-TERM CULTURE-INITIATING CELLS IN HUMAN BONE-MARROW, UMBILICAL-CORD BLOOD, AND BLOODSTEM-CELLS
    Blood
    
    R. Pettengell et al., "DIRECT COMPARISON BY LIMITING DILUTION ANALYSIS OF LONG-TERM CULTURE-INITIATING CELLS IN HUMAN BONE-MARROW, UMBILICAL-CORD BLOOD, AND BLOODSTEM-CELLS", Blood, 84(11), 1994, pp. 3653-3659
89. STRAKA C; CARR T; WILL A; COUTINHO L; DEXTER TM; TESTA N
    SUCCESSFUL EX-VIVO PURGING OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS AND SIMULTANEOUS SURVIVAL OF LONG-TERM CULTURE INITIATING CELLS IN A LONG-TERM BONE-MARROW CULTURE (LTBMC) SYSTEM
    Blood
    
    C. Straka et al., "SUCCESSFUL EX-VIVO PURGING OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS AND SIMULTANEOUS SURVIVAL OF LONG-TERM CULTURE INITIATING CELLS IN A LONG-TERM BONE-MARROW CULTURE (LTBMC) SYSTEM", Blood, 84(10), 1994, pp. 10000494-10000494
90. MOLINEUX G; MIGDALSKA A; HALEY J; EVANS GS; DEXTER TM
    TOTAL MARROW FAILURE INDUCED BY PEGYLATED STEM-CELL FACTOR ADMINISTERED BEFORE 5-FLUOROURACIL
    Blood
    
    G. Molineux et al., "TOTAL MARROW FAILURE INDUCED BY PEGYLATED STEM-CELL FACTOR ADMINISTERED BEFORE 5-FLUOROURACIL", Blood, 83(12), 1994, pp. 3491-3499
91. DEXTER TM; FAIRBAIRN LJ
    THE MOLECULAR CONTROL OF HEMATOPOIESIS
    Anti-cancer drugs
    
    T.M. Dexter e L.J. Fairbairn, "THE MOLECULAR CONTROL OF HEMATOPOIESIS", Anti-cancer drugs, 4, 1993, pp. 5-12
92. DEXTER TM
    APOPTOSIS AND LEUKEMIA - REVIEW LECTURE
    Leukemia
    
    T.M. Dexter, "APOPTOSIS AND LEUKEMIA - REVIEW LECTURE", Leukemia, 7(5), 1993, pp. 774-774
93. GILLEECE MH; HEYWORTH CM; TESTA NG; DEXTER TM
    INTERLEUKIN-4 RECEPTOR EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    Experimental hematology
    
    M.H. Gilleece et al., "INTERLEUKIN-4 RECEPTOR EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA", Experimental hematology, 21(8), 1993, pp. 1073-1073
94. COUTINHO LH; BRERETON ML; SANTOS AMW; CHANG J; HARRISON CJ; LIUYIN JA; DEXTER TM; TESTA NG
    LONG-TERM BONE-MARROW CULTURE (LTBMC) STUDIES IN CHRONIC MYELOID-LEUKEMIA (CML) - FACTORS AFFECTING THE SELECTIVE LOSS OF PH+ CELLS
    Experimental hematology
    
    L.H. Coutinho et al., "LONG-TERM BONE-MARROW CULTURE (LTBMC) STUDIES IN CHRONIC MYELOID-LEUKEMIA (CML) - FACTORS AFFECTING THE SELECTIVE LOSS OF PH+ CELLS", Experimental hematology, 21(8), 1993, pp. 1091-1091
95. BRERETON ML; COUTINHO LH; CHANG J; RICHARDS JT; HARRISON CJ; LIUYIN JA; TESTA NG; DEXTER TM
    TREATMENT OF CHRONIC MYELOID-LEUKEMIA (CML) WITH PULSE HIGH-DOSE HYDROXYUREA (HU) ALLOWS GREATER RECOVERY OF PH-CELLS IN LONG-TERM BONE-MARROW CULTURE (ITBMG) FOR AUTOTRANSPLANT
    Experimental hematology
    
    M.L. Brereton et al., "TREATMENT OF CHRONIC MYELOID-LEUKEMIA (CML) WITH PULSE HIGH-DOSE HYDROXYUREA (HU) ALLOWS GREATER RECOVERY OF PH-CELLS IN LONG-TERM BONE-MARROW CULTURE (ITBMG) FOR AUTOTRANSPLANT", Experimental hematology, 21(8), 1993, pp. 1128-1128
96. VANHOEF MEHM; BAUMANN I; LANGE C; HOWELL A; DEXTER TM; TESTA NG
    ONE APHERESIS PROCEDURE TO COLLECT PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR TRANSPLANTATION
    Experimental hematology
    
    M.E.H.M. Vanhoef et al., "ONE APHERESIS PROCEDURE TO COLLECT PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR TRANSPLANTATION", Experimental hematology, 21(8), 1993, pp. 1165-1165
97. FAIRBAIRN LJ; COWLING GJ; REIPERT BM; DEXTER TM
    SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS
    Cell
    
    L.J. Fairbairn et al., "SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS", Cell, 74(5), 1993, pp. 823-832
98. DEWYNTER E; ALLEN T; COUTINHO L; FLAVELL D; FLAVELL SU; DEXTER TM
    LOCALIZATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN HUMAN LONG-TERM BONE-MARROW CULTURES - BIOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERIZATION
    Journal of Cell Science
    
    E. Dewynter et al., "LOCALIZATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN HUMAN LONG-TERM BONE-MARROW CULTURES - BIOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERIZATION", Journal of Cell Science, 106, 1993, pp. 761-769
99. BRERETON ML; CHANG J; COUTINHO LH; HARRISON C; RICHARDS JT; DEXTER TM; TESTA NG; YIN JAL
    EVALUATION OF CYTOGENETIC CONVERSION TO PH' NEGATIVE HEMATOPOIESIS INLONG-TERM BONE-MARROW CULTURE (LTBMC) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) ON PULSE HYDROXYUREA THERAPY
    British Journal of Haematology
    
    M.L. Brereton et al., "EVALUATION OF CYTOGENETIC CONVERSION TO PH' NEGATIVE HEMATOPOIESIS INLONG-TERM BONE-MARROW CULTURE (LTBMC) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) ON PULSE HYDROXYUREA THERAPY", British Journal of Haematology, 84, 1993, pp. 36-36
100. PETTENGELL R; TESTA NG; SWINDELL R; CROWTHER D; DEXTER TM
     TRANSPLANTATION POTENTIAL OF HEMATOPOIETIC-CELLS RELEASED INTO THE CIRCULATION DURING ROUTINE CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA
     Blood
     
     R. Pettengell et al., "TRANSPLANTATION POTENTIAL OF HEMATOPOIETIC-CELLS RELEASED INTO THE CIRCULATION DURING ROUTINE CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA", Blood, 82(7), 1993, pp. 2239-2248